Amneal Pharmaceuticals Inc AMRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/27/24 EDT
6.12quote price arrow up+0.27 (+4.62%)
Volume
1,879,047
52 week range
1.24 - 6.46
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.12
  • 52 Week High6.46
  • 52 Week High Date03/19/24
  • 52 Week Low1.24
  • 52 Week Low Date03/28/23

Key Stats

  • Market Cap1.888B
  • Shares Out308.55M
  • 10 Day Average Volume1.68M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change0.82

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.12
  • 52 Week High6.46
  • 52 Week High Date03/19/24
  • 52 Week Low1.24
  • 52 Week Low Date03/28/23
  • Market Cap1.888B
  • Shares Out308.55M
  • 10 Day Average Volume1.68M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change0.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.32
  • P/E (TTM)-19.37
  • Fwd P/E (NTM)12.78
  • EBITDA (TTM)468.147M
  • ROE (TTM)-52.79%
  • Revenue (TTM)2.394B
  • Gross Margin (TTM)34.28%
  • Net Margin (TTM)-2.04%
  • Debt To Equity (MRQ)13,657.60%

EVENTS

  • Earnings Date05/03/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amneal Pharmaceuticals Inc

 

Profile

MORE
Amneal Pharmaceuticals, Inc., is a fully integrated global essential medicine company. The Company is engaged in the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. The Company’s Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermal across a broad range of...
Paul Meister
Independent Chairman of the Board
Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
Anastasios Konidaris
Chief Financial Officer, Executive Vice President
Andrew Boyer
Executive Vice President, Chief Commercial Officer - Generics
Gustavo Pesquin
Executive Vice President, Chief Commercial Officer - Speciality
Address
400 Crossing Boulevard, 3rd Floor
Bridgewater, NJ
08807
United States

Top Peers

SYMBOLLASTCHG%CHG
ENDPQ
Endo International PLC
0.0004UNCHUNCH
SUPN
Supernus Pharmaceuticals Inc
33.74+1.26+3.88%
HRMY
Harmony Biosciences Holdings Inc
33.52+1.50+4.68%
AMPH
Amphastar Pharmaceuticals Inc
43.52+0.31+0.72%
PCRX
Pacira Biosciences Inc
29.04+0.53+1.86%